JPRN-jRCTs061180072已完成2 期
Clinicopathological study on the efficacy of Cepharanthine for preventing salivary gland destruction in Sjogren's syndrome patients - Cepharanthine trial
Yamanoi Tomoko0 个研究点目标入组 14 人开始时间: 2019年3月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
This study suggests that cepharanthine may be effective in salivary glamd symptoms in patients with Sjogren's syndrome.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Outpatient 20 years or older who meets the diagnostic criteria of Sjogren's syndrome
排除标准
- •1. History of hypersensitivity to cepharanthine
- •2. Serious ischemic heart disease
- •3. Bronchial asthma and chronic obstructive pulmonary disease
- •4. Blockade of gastrointestinal tract and bladder neck
- •5. Epilepsy
- •6. Parkinsonism or Parkinson's disease
- •7. Patients with iritis
- •8. Pregnant women, lactating women or possible pregnancy
- •9. Others inappropriate
研究者
相似试验
招募中
2 期
COLE StudyOral lichen planusJPRN-jRCTs051220130Yagyuu Takahiro50
终止
4 期
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone TreatmentAcute PainNCT04716413Montefiore Medical Center3
已完成
2 期
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi SyndromeHyperphagia in Prader-Willi SyndromeNCT01968187Ferring Pharmaceuticals38
已完成
4 期
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different DosesNasal CongestionNCT00648973Johnson & Johnson Consumer and Personal Products Worldwide1,021
已完成
不适用
A case-control study evaluating the efficacy and safety of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosisJPRN-UMIN000016045Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo,27